Browse by People

Clarke, JI, Forootan, SS, Lea, JD, Howell, LS, Rodriguez, JM, Kipar, A ORCID: 0000-0001-7289-3459, Goldring, CE, Park, BK ORCID: 0000-0001-8384-824X, Copple, IM ORCID: 0000-0003-4101-1913 and Antoine, DJ (2017) Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies. TOXICOLOGY RESEARCH, 6 (4). pp. 406-411.

Collapse authors list.
Shelton, LM, Lister, A, Walsh, J, Jenkins, RE, Wong, MHL, Rowe, C, Ricci, E ORCID: 0000-0001-9751-0661, Ressel, L ORCID: 0000-0002-6614-1223, Fang, Y ORCID: 0000-0002-4514-5292, Demougin, P et al (show 7 more authors) , Vukojevic, V, O Neill, PM, Goldring, CE, Kitteringham, NR, Park, BK ORCID: 0000-0001-8384-824X, Odermatt, A and Copple, IM ORCID: 0000-0003-4101-1913 (2015) Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney. KIDNEY INTERNATIONAL, 88 (06). pp. 1261-1273.

Greensmith, RMD (2017) Novel approaches in the management of bladder cancer. PhD thesis, University of Liverpool.

Collapse authors list.
Evans, JP, Winiarski, BK, Sutton, PA, Jones, RP ORCID: 0000-0001-5608-001X, Ressel, L ORCID: 0000-0002-6614-1223, Duckworth, CA ORCID: 0000-0001-9992-7540, Pritchard, DM ORCID: 0000-0001-7971-3561, Lin, ZX, Vicky, FL, Tweedle, EM et al (show 6 more authors) , Costello, E, Goldring, CE, Copple, IM ORCID: 0000-0003-4101-1913, Park, BK ORCID: 0000-0001-8384-824X, Palmer, DH ORCID: 0000-0002-7147-5703 and Kitteringham, NR (2018) The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer. Oncotarget, 9 (43). pp. 27104-27116.

Collapse authors list.
O'Neill, PM ORCID: 0000-0003-4338-0317, Amewu, RK ORCID: 0000-0002-4676-436X, Charman, SA, Sabbani, S, Gnädig, NF, Straimer, J, Fidock, DA, Shore, ER, Roberts, NL, Wong, MH-L et al (show 38 more authors) , Hong, WD, Pidathala, C, Riley, C, Murphy, B, Aljayyoussi, G, Gamo, FJ, Sanz, L, Rodrigues, J, Cortes, CG, Herreros, E, Angulo-Barturén, I, Jiménez-Díaz, MB, Bazaga, SF, Martínez-Martínez, MS, Campo, B, Sharma, R, Ryan, E, Shackleford, DM, Campbell, S, Smith, DA, Wirjanata, G, Noviyanti, R, Price, RN, Marfurt, J, Palmer, MJ, Copple, IM ORCID: 0000-0003-4101-1913, Mercer, AE ORCID: 0000-0002-7399-8655, Ruecker, A, Delves, MJ, Sinden, RE, Siegl, P, Davies, J, Rochford, R, Kocken, CHM, Zeeman, A-M, Nixon, GL, Biagini, GA and Ward, SA (2017) A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance. Nature Communications, 8 (1). 15159-.